TITLE

LUNG CANCER DELIVERY OF CARE

PUB. DATE
December 2001
SOURCE
Thorax;Dec2001 Supp, Vol. 56, piii59
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article presents various studies related to lung cancer care. There is a national shortage in Great Britain of Thoracic Surgeons with many unfilled posts, however Guidelines for the Management of Lung Cancer recommend surgical input to the regular MDT meeting at every Cancer Centre/Unit. Most patients with non-small cell lung cancer are unsuitable for surgical resection and are therefore referred to thoracic oncologists for radiotherapy or chemotherapy. Patients with lung cancer often present with advanced disease. It has been suggested that this is due to patients failure to recognize symptoms and seek medical advice.
ACCESSION #
12965137

 

Related Articles

  • Supportive care in patients with advanced non-small-cell lung cancer. Di Maio, M.; Perrone, F.; Gallo, C.; Iaffaioli, R.V.; Manzione, L.; Piantedosi, F.V.; Cigolari, S.; Illiano, A.; Barbera, S.; Robbiati, S.F.; Piazza, E.; Ianniello, G.P.; Frontini, L.; Veltri, E.; Castiglione, F.; Rosetti, F.; De Maio, E.; Maione, P.; Gridelli, C. // British Journal of Cancer;9/15/2003, Vol. 89 Issue 6, p1013 

    The present study describes supportive care (SC) in patients with advanced non-small-cell lung cancer (NSCLC), evaluating whether it is affected by concomitant chemotherapy, patient's performance status (PS) and age. Data of patients enrolled in three randomised trials of first-line...

  • Amifostine: potential to alleviate oesophagitis, QOL in NSCLC.  // PharmacoEconomics & Outcomes News;6/4/2005, Issue 479, p12 

    Discusses research being done on the effect of amifostine on locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation. Reference to a study by B. Movsas et al, published in the April 2005 issue of the "Journal of Clinical Oncology"; Inefficacy...

  • Specialists seek fairer lung cancer service provision to boost survival. Waters, Adele // Nursing Standard;11/23/2005, Vol. 20 Issue 11, p12 

    The article presents information on seeking up of fairer lung cancer service provision by the specialist nurses to boost the survival rates among lung cancer patients. The nurses have joined forces with thoracic surgeons to set up the UK Lung Cancer Coalition (UKLCC), which will struggle to cut...

  • Differences in Practice Patterns and Costs between Small Cell and Non-Small Cell Lung Cancer Patients in Japan. Kuwabara, Kazuaki; Matsuda, Shinya; Fushimi, Kiyohide; Anan, Makoto; Ishikawa, Koichi B.; Horiguchi, Hiromasa; Hayashida, Kenshi; Fujimori, Kenji // Tohoku Journal of Experimental Medicine;Jan2009, Vol. 217 Issue 1, p29 

    Many reports exist regarding the economic evaluation of evolving chemotherapeutic regimens or diagnostic images for lung cancer (LC) patients. However, it is not clear whether clinical information, such as pathological diagnosis or cancer stage, should be considered as a risk adjustment in lung...

  • Gemcitabine and pemetrexed administered in rapid sequence as front-line chemotherapy for advanced non-small-cell lung cancer: a phase II clinical trial. West, H. L.; Wakelee, H. A.; Perry, M. C.; Belt, R. J.; Chen, R.; Obasaju, C. // Annals of Oncology;May2009, Vol. 20 Issue 5, p850 

    Background: Previous studies of the gemcitabine–pemetrexed combination in patients with late-stage non-small-cell lung cancer (NSCLC) utilized a 90-min delay between gemcitabine and pemetrexed administration. This phase II study evaluated activity when these agents were administered...

  • Radiochemotherapy toxicity costly in HNC, NSCLC patients.  // PharmacoEconomics & Outcomes News;11/1/2008, Issue 565, p6 

    The article compares the costs for patients with head and neck cancer (HNC) and those with non-small cell lung cancer (NSCLC) who received radiochemotherapy. A U.S. study used data from the medical charts of 139 patients with HNC or NSCLC to determine the costs of radiochemotherapy induced...

  • Excision Repair Cross-Complementation Group 1 (ERCC1) Status and Lung Cancer Outcomes: A Meta-Analysis of Published Studies and Recommendations. Hubner, Richard A.; Riley, Richard D.; Billingham, Lucinda J.; Popat, Sanjay // PLoS ONE;2011, Vol. 6 Issue 10, p1 

    Purpose: Despite discrepant results on clinical utility, several trials are already prospectively randomizing non-small cell lung cancer (NSCLC) patients by ERCC1 status. We aimed to characterize the prognostic and predictive effect of ERCC1 by systematic review and meta-analysis. Methods:...

  • Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study. Gregor, A.; Thomson, C. S.; Brewster, D. H.; Stroner, P. L.; Davidson, J.; Fergusson, R. J.; Milroy, R. // Thorax;Mar2001, Vol. 56 Issue 3, p212 

    Background-The prognosis of patients with lung cancer in Scotland is poor and not improving. This study was designed to document factors influencing referral, diagnostic evaluation, treatment, and survival in patients with lung cancer. Methods-Patients diagnosed during 1995 were identified from...

  • How do patient and hospital features influence outcomes in small-cell lung cancer in England? Rich, A. L.; Tata, L. J.; Free, C. M.; Stanley, R. A.; Peake, M. D.; Baldwin, D. R.; Hubbard, R. B. // British Journal of Cancer;9/6/2011, Vol. 105 Issue 6, p746 

    Background:Our aim was to systematically determine how features of patients and hospitals influence access to chemotherapy and survival for people with small-cell lung cancer in England.Methods:We linked the National Lung Cancer Audit and Hospital Episode Statistics and used multiple logistic...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics